Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infection
Detection Principle
ImmunoAssay-Antibody
Target
IgG
Testing Method Category
Other Immuno assay
Testing Method
kit (Abbott)
Testing Method - Additional Info
Abbott Architect SARS-CoV-2 IgG assay
Reported Performance
Specificity: 100%; Sensitivity: 8.6% (?6 dpo), 43.6% (7–13 dpo), 84.0% (14–20 dpo), 84.4% (?21 dpo)
Sample Size
340 samples
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements